Free Trial
NASDAQ:NTHI

Neonc Technologies Q3 2025 Earnings Results & Report

Neonc Technologies logo
$2.66 +0.06 (+2.31%)
Closing price 04:00 PM Eastern
Extended Trading
$2.70 +0.04 (+1.50%)
As of 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neonc Technologies reported Q3 2025 earnings on November 14, 2025. The company reported EPS of -$0.45.

Earnings Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call
7:00 AM ET

Neonc Technologies EPS Results

Actual EPS
-$0.45
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Neonc Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Neonc Technologies' Q3 2026 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, November 10, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Neonc Technologies Q3 2025 Earnings FAQ

Neonc Technologies (NASDAQ:NTHI) reported earnings of -$0.45 per share for Q3 2025. The report was announced on Friday, November 14, 2025.

Neonc Technologies' next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Neonc Technologies on the company's earnings history page.

Neonc Technologies Earnings Headlines

NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors
Federal Reserve Reveals Disturbing New Plan To Control Your Money
A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.tc pixel
NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt
See More Neonc Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Neonc Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neonc Technologies and other key companies, straight to your email.

About Neonc Technologies

Neonc Technologies (NASDAQ:NTHI) develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

View Neonc Technologies Profile